Jérémie Guedj Selected Research

Jérémie Guedj Research Topics

13	Infections 01/2024 - 01/2006
8	COVID-19 02/2024 - 01/2020
4	Neoplasms (Cancer) 04/2024 - 10/2019
4	Ebola Hemorrhagic Fever 01/2021 - 03/2016
3	Prostatic Neoplasms (Prostate Cancer) 07/2017 - 05/2015
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 10/2023
2	Urinary Bladder Neoplasms (Bladder Cancer) 07/2023 - 12/2020
2	Carcinoma (Carcinomatosis) 01/2023 - 10/2019
2	Pneumonia (Pneumonitis) 01/2022 - 01/2022
2	Virus Diseases (Viral Diseases) 01/2021 - 01/2020
2	Cytokine Release Syndrome 01/2021 - 10/2018
2	Human Influenza (Influenza) 01/2020 - 03/2016
2	Fever (Fevers) 01/2018 - 01/2017
2	Viremia 01/2017 - 03/2016
1	Hepatitis B 01/2023
1	Dysbiosis 01/2022
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Hepatorenal Syndrome 01/2022
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022
1	Chronic Renal Insufficiency 01/2022
1	Lymphopenia (Lymphocytopenia) 10/2021
1	Lassa Fever (Fever, Lassa) 01/2021
1	Sepsis (Septicemia) 01/2017
1	Body Weight (Weight, Body) 01/2017
1	Malaria 12/2015
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2006

13	favipiravirIBA 12/2021 - 03/2016
9	Antiviral Agents (Antivirals)IBA 09/2023 - 03/2016
5	atezolizumabIBA 04/2024 - 10/2019
3	remdesivirIBA 01/2022 - 10/2018
3	Prostate-Specific Antigen (Semenogelase)IBA 07/2017 - 05/2015
2	AntigensIBA 11/2023 - 01/2023
2	B7-H1 AntigenIBA 01/2023 - 10/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2022
2	Ribavirin (Virazole)FDA LinkGeneric 01/2022 - 01/2021
2	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 01/2020 - 01/2017
1	tixagevimabIBA 02/2024
1	cilgavimab and tixagevimab drug combinationIBA 02/2024
1	cilgavimabIBA 02/2024
1	3- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA 12/2023
1	tecovirimatIBA 12/2023
1	Neutralizing AntibodiesIBA 10/2023
1	InterferonsIBA 01/2023
1	Hepatitis B e AntigensIBA 01/2023
1	Viral RNAIBA 01/2023
1	Lamivudine (Epivir)FDA Link 01/2023
1	EnzymesIBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	molnupiravirIBA 12/2021
1	COVA1-18IBA 10/2021
1	NucleotidesIBA 01/2021
1	CytokinesIBA 01/2021
1	VaccinesIBA 01/2020
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2020
1	Mefloquine (Lariam)FDA LinkGeneric 12/2015
1	ArtesunateIBA 12/2015

6	Immunotherapy 04/2024 - 10/2019
5	Therapeutics 01/2024 - 01/2017
3	Drug Therapy (Chemotherapy) 10/2023 - 01/2017
2	Castration 07/2017 - 05/2015
1	Contraindications 01/2022
1	Phage Therapy 01/2022
1	Mechanical Ventilators (Ventilator) 01/2022
1	Personal Protective Equipment 01/2021
1	Highly Active Antiretroviral Therapy (HAART) 01/2006